Evidence-Based Treatment of Cerebrovascular Disease

Evidence-Based Management of Intracerebral Hemorrhage

Michael Diringer, M.D. -- Department of Neurology, Neurological Surgery, and Occupational Therapy
Washington University School of Medicine -- Presented August 1, 2006

Baseline Characteristics

Subjects	96	108	92	103
Male	53%	63%	61%	67%
Age, years	68 ± 12	67 ± 12	65 ± 12	64 ± 13
White	81%	77%	86%	80%
Asian	15%	19%	10%	15%
ICH volume, mL	24 ± 22	22 ± 22	23 ± 24	26 ± 30
Lobar location	21%	18%	25%	18%
Dosed 0-3 hours	72%	62%	76%*	71%
Dosed 3-4 hours	28%	38%	23%*	29%

Back

Table of Contents

All References

References

Mayer SA, Begtrup K, Broderick J et al. Recombinant Activated Factor VII Intercerebral Hemorrhage Trial Investigators.
Recombinant activated factor VII for acute intracerebral hemorrhage.
N Engl J Med. 2005 Feb 24;352(8):777-85.